Centrus Q2 2026 earnings: Revenue rose while GAAP profit fell

Centrus Energy (NYSE: LEU) reported Q2 2026 revenue of $176.1 million, up 14% from $154.5 million, while diluted GAAP EPS fell to $0.77 from $1.59. Uranium sales lifted the top line, but lower SWU volume, a Technical Solutions gross loss, expansion-related spending and stock compensation weighed on GAAP profitability.

Core financial results

Revenue growth did not translate into higher gross profit. Gross margin fell by approximately 6.6 percentage points, while higher operating expenses reduced operating income to $10.4 million.

Adjusted results exclude $10.6 million of growth costs and $17.7 million of stock-based compensation. Adjusted net income increased, but adjusted diluted EPS declined as the average diluted share count rose to 21.9 million from 18.1 million.

Business and segment performance

The LEU segment generated most of the quarter’s revenue growth, but its gross profit increased only modestly. Technical Solutions moved from a gross profit to a loss as revenue from the 2022 DOE HALEU operation contract declined.

SWU sales volume declined 23%, more than offsetting a 3% increase in average selling price. The average unit cost of SWU sold increased 13%, adding pressure to LEU segment margins. Centrus said quarterly LEU profitability can also vary because customers have annual rather than quarterly purchase commitments and delivery pricing depends on when contracts were signed.

Technical Solutions revenue fell primarily because the DOE HALEU operation contract contributed $5.9 million less revenue. Lower contract costs did not fully offset the revenue decline, and the segment recorded a $1.7 million gross loss.

Profitability, cash flow and the balance sheet

Selling, general and administrative expenses nearly doubled to $26.2 million from $13.4 million. Centrus attributed the increase mainly to a $17.2 million rise in stock-compensation expense tied to RSU tax withholdings. Advanced technology costs also increased to $10.8 million from $3.3 million as the company prepared to expand uranium enrichment operations.

These items explain much of the gap between GAAP and adjusted earnings. Adjusted operating income, which removes growth costs and stock compensation, was $38.7 million compared with $40.8 million a year earlier. Higher investment income of $16.3 million, up from $8.0 million, partially supported net income despite weaker operating profit.

Centrus provided cash-flow figures only for the six months ended June 30, so they should not be interpreted as Q2-only results. First-half operating cash flow was negative $16.7 million, compared with positive $89.3 million a year earlier. A $92.5 million use of cash for inventory and a $38.4 million decrease in deferred revenue and customer advances were important factors.

First-half capital expenditures increased to $94.8 million from $5.7 million. At June 30, Centrus held $1.87 billion of cash and cash equivalents, compared with $1.96 billion at the end of 2025, while long-term debt was $1.18 billion. Property, plant and equipment rose to $142.5 million from $29.5 million, reflecting the expanding industrial buildout.

Backlog is large, but parts remain conditional or funding-dependent

Total backlog was $4.5 billion at June 30 and extended through 2040. The LEU segment accounted for approximately $3.7 billion, including about $3.0 billion of contingent LEU and HALEU sales commitments. Approximately $2.4 billion of those contingent commitments are under definitive agreements, but they remain linked to operational milestones associated with potential new production capacity in Piketon, Ohio.

Technical Solutions backlog was approximately $0.8 billion. The proposed DOE fiscal 2027 budget does not include additional funding for operation of the HALEU cascade under the 2022 contract, and DOE has said it does not currently intend to exercise further options. That contract represents approximately $0.8 billion of Technical Solutions backlog, creating uncertainty over how much of the reported amount will become revenue.

Separately, Centrus signed a $900 million DOE HALEU enrichment award contract and its first large-scale commercial HALEU supply agreement, which may include customer prepayments. The release did not quantify the timing or amount of any such prepayments.

2026 guidance

Centrus updated parts of its full-year financial and operational outlook. The only explicit comparison with earlier guidance was for Piketon hiring, which increased from 100 to at least 175 net new employees.

The capital deployment range reflects increased investment in centrifuge manufacturing and the broader industrial expansion. Other operational goals include finalizing contracts with critical partners and releasing a Certified for Construction package.

Management perspective

Management described enrichment demand as healthy and supply as constrained, with upward pressure on SWU prices. However, the quarter’s results show that higher market pricing did not offset lower SWU delivery volume and rising unit costs.

Centrus said it has secured a majority of suppliers considered critical through larger commitments intended to reduce exposure to price fluctuations. The company also selected Geiger Brothers as construction contractor for its enrichment plant expansion and expects to complete the first new centrifuge in Oak Ridge by the end of 2026.

Recent insider transactions

The supplied six-month summary lists 9,754 shares across eight transactions classified as purchases and 306 shares in one sale, producing net purchases of 9,448 shares. Because the detailed records include stock awards and an option exercise, the aggregate should not be interpreted as open-market buying.

Several directors also received stock awards on June 18, 2026, but the supplied records did not include the number or value of shares awarded.

Risks investors should monitor

• SWU economics: Sales volume fell 23% while average unit cost increased 13%. Continued cost increases or delivery weakness could pressure LEU margins even if market prices rise.
• Backlog conversion: Approximately $3.0 billion of LEU and HALEU commitments are contingent on operational milestones, while the Technical Solutions backlog faces DOE funding and option-exercise uncertainty.
• Expansion cash requirements: First-half operating cash flow was negative and capital expenditures increased substantially. The planned $350 million to $500 million of 2026 capital deployment raises the importance of execution, customer prepayments and liquidity management.
• Supply and trade restrictions: Centrus’ guidance assumes no significant change in its ability to receive and sell Russian LEU or other uranium products. Changes in restrictions could affect supply, deliveries and financial results.

Summary

Centrus’ Q2 2026 results combined higher revenue with lower GAAP profitability. Uranium sales supported LEU segment growth, but lower SWU volume, rising unit costs, a Technical Solutions loss and higher expansion-related expenses limited profit conversion. The main issues to monitor are whether Centrus can turn conditional backlog into funded revenue, execute its capital-intensive enrichment expansion and stabilize margins as new centrifuge capacity is developed.